CAP for Tokyo lab coincides with rising demand, Quintiles

By Gareth Macdonald

- Last updated on GMT

Related tags Contract research organization Clinical trial

Quintiles says CAP accreditation for Tokyo central lab strengthens position in Japan’s fast growing innovative drug development sector.

The laboratory, set up earlier​ this year to house operations previously based in Saitama, received the designation after what SVP of global central labs Thomas Wollman said had been an extensive audit process.

Wollman told Outsourcing-pharma that: “The certification process is intended to improve patient safety by advancing the quality of pathology and laboratory services through education, setting standards and ensuring laboratories meet or exceed regulatory requirements​.”

College of American Pathologists (CAP) accreditation,” ​Wollman continued,” has become a global quality standard and is proof of good technical and management practice​.”

He also suggested that accreditation will boost Quintiles’ lab business in Japan, explaining that since entering the market in 2008​ in a deal with Medeca the industry has changed significantly.

Japan is quickly becoming a key destination for biopharmaceutical development and innovation and we are seeing customer demand for our services continue to grow​.”

Japan’s drug development growth

Wollman’s comments, and the upswing in demand for lab analysis services, are in keeping with the expansion seen in Japan’s clinical trials sector in recent years.

While in previous years the strict rules governing research in Japan put many drugmakers off conducting trials the country, in the last few years​ government measures designed to accelerate the process have changed the market.

Initially this resulted in a large number of international contract research organisations (CRO) forming partnerships with Japanese firms to access the market.

More recently however the focus has been on ancillary trial services and preclinical development. For example both Thermo Fisher Scientific​ and Lab Research​ have expanded their business in the country in recent months.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us